市场调查报告书
商品编码
1290783
肾造口设备市场 - 按产品(导丝、引流管、肾造口导管、鞘内扩张器),按最终用途(医院、诊所、流动手术中心)及全球预测,2023 - 2032年Nephrostomy Devices Market - By Product (Guidewires, Drainage Tubes, Nephrostomy Catheters, Sheath Dilators), By End-use (Hospitals, Clinics, Ambulatory Surgical Centers) & Global Forecast, 2023 - 2032 |
全球肾造口设备市场规模将在2032年之前大幅扩张。对肾脏疾病的认识不断提高,增加了对肾造瘘设备的需求。这一领域的行业参与者正在把他们的综合努力投入到研发中,以推出具有先进功能的肾造口术设备来满足这一不断增长的需求。例如,2023年4月,著名的医疗设备公司库克医疗推出了LithAssist(TM),这是一款结合了抽吸控制和提供激光纤维接入的设备。这种新设备将有助于简化经皮肾镜取石术(PCNL)程序,以简化结石管理和治疗。
微创技术的进步,如图像引导下的肾造瘘术,改善了病人的治疗效果,增加了肾造瘘手术的采用。此外,肾造瘘手术的报销政策的出台将刺激行业收入来源,直到2032年。
整个肾造瘘设备市场根据产品、终端用途和地区进行细分。
从2023年到2032年,肾造口导管市场份额将以体面的复合年增长率增长。人口迅速老龄化对肾脏疾病的易感性增加了对肾造口导管的需求。此外,细分市场的扩张也可归功于产品的不断进步。事实上,在导管上引入抗菌涂层有助于减少感染的风险。另一方面,导管材料的改进提高了病人的舒适度,减少了并发症的可能性,有利于市场增长。
根据最终用途,非住院手术中心部分的肾造口设备市场价值将在2032年之前积累相当大的收益。在非住院手术中心,各种先进的肾造口术设备的高可用性使其成为首选的医疗保健提供者。这些设施为病人提供了更多的便利和更舒适的环境,简化了入院和出院流程。它们还提供比其他设施更有成本效益的治疗,从而使患者人数增加。
在区域方面,从2023年到2032年,欧洲肾造口设备市场份额将以有利可图的复合年增长率增长。对微创手术的需求不断增长,以及整个地区医疗基础设施的迅速扩大,将促进市场增长。此外,该地区的市场增长也可归功于易患肾脏疾病的老龄人口的增长。
欧洲也是著名的市场竞争者的所在地,如B. Braun Melsungen AG和其他专注于产品创新以扩大其存在。例如,2022年9月,德国医疗设备公司B. Braun Melsungen AG宣布从Starboard Medical, Inc.收购Clik-FIX导管固定设备目录。
Global Nephrostomy Devices Market size will expand substantially through 2032. Growing awareness about kidney disorders has increased the need for nephrostomy devices. Industry players in this space are putting their consolidated efforts into R&D to launch nephrostomy devices with advanced capabilities to cater to this growing demand. For instance, in April 2023, Cook Medical, a prominent medical device company, unveiled LithAssist™, a device that combines suction control and offers laser fiber access. This new device will help simplify percutaneous nephrolithotomy (PCNL) procedures to streamline stone management and treatment.
Advancements in minimally invasive techniques, such as image-guided nephrostomy, have improved patient outcomes and increased the adoption of nephrostomy procedures. Besides, the availability of reimbursement policies for nephrostomy procedures will stimulate industry revenue streams through 2032.
The overall nephrostomy devices market is segmented based on product, end-use, and region.
Nephrostomy catheters market share will grow at a decent CAGR from 2023 to 2032. The rapidly aging population's susceptibility to kidney disorders has increased the need for nephrostomy catheters. Moreover, segment expansion can also be credited to growing advancements in the product. In fact, the introduction of antimicrobial coatings on catheters has helped reduce the risk of infection. On the other hand, improvements in catheter materials have improved patient comfort and reduced the likelihood of complications, favoring market growth.
Based on end-use, nephrostomy devices market value from the ambulatory surgical centers segment will amass considerable gains through 2032. High availability of a wide range of advanced nephrostomy devices in ambulatory surgical centers has made them a preferred healthcare provider. These facilities provide more convenience and a more comfortable environment for patients, with streamlined admission and discharge processes. They also provide more cost-effective treatment than other facilities, resulting in an increased patient footfall.
On the regional front, Europe nephrostomy devices market share will grow at a lucrative CAGR from 2023 to 2032. The growing demand for minimally invasive procedures and the rapidly expanding healthcare infrastructure across the region will contribute to the market growth. Moreover, the regional market growth can also be credited to the growing aging population prone to kidney diseases.
Europe is also home to prominent market contenders such as B. Braun Melsungen AG and others focusing on product innovations to expand their presence. For instance, in September 2022, B. Braun Melsungen AG, a German medical device company, announced the acquisition of the Clik-FIX catheter securement device catalog from Starboard Medical, Inc.